Interrelationship of Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus colonization within and between pneumococcal-vaccine naïve mother-child dyads by Shiri, Tinevimbo et al.
 http://wrap.warwick.ac.uk  
 
 
 
 
 
 
 
 
 
 
Original citation: 
Shiri, Tinevimbo, Nunes, Marta C., Adrian, Peter V., Van Niekerk, Nadia, Klugman, Keith 
P. and Madhi, Shabir A.. (2013) Interrelationship of Streptococcus pneumoniae, 
Haemophilus influenzae and Staphylococcus aureus colonization within and between 
pneumococcal-vaccine naïve mother-child dyads. BMC Infectious Diseases, 13 . 483. 
 
Permanent WRAP url: 
http://wrap.warwick.ac.uk/75475        
       
Copyright and reuse: 
The Warwick Research Archive Portal (WRAP) makes this work of researchers of the 
University of Warwick available open access under the following conditions. 
 
This article is made available under the Creative Commons Attribution 2.0 Generic (CC 
BY 2.0) license and may be reused according to the conditions of the license.  For more 
details see: http://creativecommons.org/licenses/by/2.0/ 
 
A note on versions: 
The version presented in WRAP is the published version, or, version of record, and may 
be cited as it appears here. 
 
For more information, please contact the WRAP Team at: publications@warwick.ac.uk  
RESEARCH ARTICLE Open Access
Interrelationship of Streptococcus pneumoniae,
Haemophilus influenzae and Staphylococcus
aureus colonization within and between
pneumococcal-vaccine naïve mother-child dyads
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and Shabir A Madhi1,2,3*
Abstract
Background: A high prevalence of bacterial nasopharyngeal co-infections has been reported in children, however,
such data is limited in adults. We examined the interaction of Haemophilus influenzae, Staphylococcus aureus and
Streptococcus pneumoniae pharyngeal colonization in mother-child dyads.
Methods: Pneumococcal-vaccine naïve children and their mothers had pharyngeal swabs undertaken at 1.6, 2.5,
3.5, 4.5, 7.4, 9.5, 12.5, 16.2 and 24.2 months of child’s age. Swabs were cultured for S. pneumoniae, H. influenzae and
S. aureus using standard microbiologic methods. Multivariate generalized estimating equation-models were used to
explore the associations of the three bacteria within and between children and their mothers.
Results: In children, the observed probability of co-colonization was higher than expected. Well-defined
associations in colonization between the bacteria were observed in children but not among mothers. In children, a
synergistic association was observed between S. pneumoniae and H. influenzae (Adjusted odds ratio (AOR): 1.75,
95% CI: 1.32-2.32) and a negative association between S. pneumoniae and S. aureus (AOR: 0.51, 95% CI: 0.39-0.67) or
H. influenzae and S. aureus (AOR: 0.24, 95% CI: 0.16-0.34) colonization. Additionally, all three bacteria had a higher
likelihood of concurrent colonization. There was a strong association in colonization by the bacteria in children and
their mothers, including increased likelihood of maternal colonization if the child was colonized by S. pneumoniae
(AOR: 1.84, 95% CI: 1.28-2.63) and H. influenzae (AOR: 6.34, 95% CI: 2.24-18.0).
Conclusions: The effects of immunization of children with pneumococcal-conjugate-vaccine in settings such as
ours needs monitoring with regard to potential changes of pharyngeal bacterial ecology which could occur in
vaccinated and –unvaccinated age-groups.
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Background
Streptococcus pneumoniae is commonly associated with
colonization of the nasopharynx (NP) in children,
with variable co-colonization by other bacteria such
as Staphylococcus aureus, Moraxella catarrhalis and
Haemophilus influenzae [1-5]. Although generally
asymptomatic, colonization by these bacteria is part
of the pathogenesis to developing invasive and mu-
cosal disease [6].
A negative association for colonization between S.
pneumoniae and S. aureus; and H. influenzae and S.
aureus has been reported in otherwise healthy chil-
dren [1,7-9], but not so among asymptomatic and
hospitalized human immunodeficiency virus (HIV)-
infected children [10,11]. Furthermore, a positive as-
sociation has been observed for H. influenzae and S.
pneumoniae colonization among children, irrespective
of HIV-infection status [10-12].
There are limited studies on nasopharyngeal bacterial
colonization associations within and between mother
and infant pairs. Lebon et al. reported an association for
colonization with S. aureus and H. influenzae, but not S.
pneumoniae and M. catarrhalis, between mothers and
their children [13]. Bacterial interactions in the NP can
be altered by treatments and vaccines [14]. Previous
studies have demonstrated subsequent changes in other
bacteria following the introduction of pneumococcal
conjugate vaccine (PCV) [15-18]. Understanding the
nasopharyngeal interaction of these bacteria within and
between mothers and their children could assist in
predicting the potential impact of PCV immunization on
the ecology of nasopharyngeal bacterial colonization and
transmission patterns of these bacteria.
The aim of this study was to determine the association
of maternal colonization with S. pneumoniae, H.
influenzae and S. aureus and colonization with the same
bacteria in children. In addition, we explored the correl-
ation of colonization statuses of mothers and children.
Methods
Ethics statement
This study was approved by the Human Research Ethics
Committee (HREC number: 050705) at the University of
the Witwatersrand, Johannesburg, South Africa. Signed
informed consent for collection of the isolates was
obtained from the mothers.
Study design
The data sets were derived from a cohort study in So-
weto, South Africa, involving infants and their mothers
as described in Nunes et al. 2013 [19]. Briefly, 251 PCV-
naïve infants 6–12 weeks of age and their mothers were
followed until two years of age between January 2007
and May 2009. Infants were stratified as being: i) born to
HIV-infected mothers, but who were HIV-uninfected
themselves based on a negative HIV-polymerase chain
reaction (Roche Amplicor RNA PCR, version 1.5, Roche
Molecular Systems, Inc. Branchburg, NJ, USA) at base-
line and in the absence of being breast-fed (HEU); and
ii) infants born to mothers who were sero-negative for
HIV after 24 weeks of gestational age during pregnancy
and the infant was also sero-negative for HIV at enrol-
ment (HUU).
Nasopharyngeal sampling for culture of Streptococcus
pneumoniae, Staphylococcus aureus and Haemophilus
influenzae carriage were undertaken in the mother-child
dyad at 1.6, 2.5, 3.5, 4.5, 7.4, 9.5, 12.5, 16.2, and 24.2
months of the child’s chronological age. In addition,
oropharyngeal swabs were also undertaken for bac-
terial culture among the mothers. Infants received all
their scheduled childhood vaccines which included
Haemophilus influenzae type b conjugate vaccine,
while PCV was unavailable at the time of the study.
Swabs were cultured for pneumococci according to stand-
ard methods [20] and serotyped by the Quellung method
(Statens Serum Institute, Copenhagen, Denmark) at the
National Institute for Communicable Diseases, South
Africa. Serotype 6C was distinguished from serotype
6A by PCR [21]. Strains which did not react by the
Quellung method were confirmed as being pneumo-
cocci by lytA PCR detection and categorized as non-
typeable. Pneumococcal isolates were categorized as
PCV13 serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C,
19A, 19F, 23F) or non-PCV13 serotypes (all other
serotypes and non-typeable isolates). Colonization for
S. pneumoniae, S. aureus and H. influenzae as a bin-
ary variable was established for each time point. Data from
all the children and the mothers with at least one sample
were included in the analysis.
Statistical analyses
A Mann-Kendall test for detecting trends was used to
examine the relationship between participant age and the
prevalence of bacteria. Patterns of possible associations of
the three bacteria were analyzed by fitting generalized
estimating equations (GEE) models with an exchangeable
correlation structure and the logit link function, i.e. we
modelled colonization by each bacterium separately with
colonization of the other two bacterial species, including
the interaction of these two other bacteria, as independent
variables. Also, age of the study participant, influenza virus
season, season of the year when the sample was taken,
presence of a child in the household between the ages of 3
and 6 years, use of coal/wood for fuel in the household,
presence of a sibling attending day care and presence of a
smoker in the household were included in the model to
adjust for potential confounding. Participants who were not
colonized by pneumococcus were used as the reference
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group in our GEE models. Adjusted odds ratios (AOR) to-
gether with 95% confidence intervals (95% CI) were used as
measures of association. All statistical analyses were
performed with SAS version 9.2 software (SAS Institute,
Inc., NC, USA).
Results
A total of 1844 samples from 251 children (median 8 sam-
ples per child) were obtained, including 983 from 126 HEU
children and 861 samples from 125 HUU children. Simi-
larly, 1835 samples from 251 mothers (median 8 per
mother) were evaluated, including 985 samples from 126
HIV-infected mothers and 850 samples from 125 HIV-
uninfected mothers. A total of 1830 specimens from 251
mother-child pairs had concurrent samples at the same
visit.
The prevalence of bacterial colonization at individual
time points in both children and mothers are shown in
Figure 1 (see also Additional file 1: Table S1). In children,
there was an upward trend in prevalence of H. influenzae
(p = 0.0003) and S. pneumoniae (p = 0.002) colonization
with increasing age, while there was a decline in S. aureus
colonization (p = 0.02) with age. Among mothers, the
prevalence of S. pneumoniae (p = 0.002) and H. influenzae
(p = 0.008) colonization also increased over time as the
child became older, however, no changes were observed in
prevalence of S. aureus colonization which remained
greater than 50% throughout the study (Figure 1).
Bacterial colonization associations in children
The overall detection of colonization in children was
59.8% (1094/1830) for S. pneumoniae, 32.3% (591/1830)
for H. influenzae and 26.6% (487/1830) for S. aureus.
The observed probability of bacterial co-colonization,
either dual or triple, at a particular time-point was
higher than expected (calculated from the assumption
that colonization was an independent process and not
random), i.e. pathogens were found together more often
than would be expected by chance as shown in Figure 2.
Carriage of H. influenzae increased the odds of subse-
quent colonization with S. pneumoniae (AOR: 1.75, 95%
CI: 1.32-2.32), but not vice-versa (AOR: 1.14, 95% CI:
0.90-1.44) (Table 1). There was a greater likelihood of
childhood colonization by H. influenzae if colonized by
PCV13 serotypes (AOR: 1.45, 95% CI: 1.09-1.93) and
vice-versa, i.e., increased likelihood of colonization by
PCV13 serotypes if colonized by H. influenzae (AOR:
1.75, 95% CI: 1.28-2.39). A similar, albeit non-significant
trend was also observed for colonization between H.
influenzae and non-PCV13-serotypes (AOR: 1.35,
95% CI: 0.96-1.90) and vice-versa (AOR: 1.36, 95%
CI: 0.96-1.91).
Colonization by S. pneumoniae was associated with a re-
duced odds of concurrent S. aureus colonization (AOR:
0.68, 95% CI: 0.50-0.93) and vice-versa (AOR: 0.51,
95% CI: 0.39-0.67). This was not differentially affected by
pneumococcal PCV13-serotype status. When stratified
according to PCV13-serotypes, carriage of S. aureus de-
creased the odds of colonization by PCV13-serotypes
(AOR: 0.48, 95% CI: 0.36-0.65) and non-PCV13-serotype
(AOR: 0.39, 95% CI: 0.29-0.54) (Table 1).
There was a negative association between colonization by
H. influenzae and S. aureus; AOR: 0.24, 95% CI: 0.16-0.34
and vice-versa (AOR: 0.58, 95% CI: 0.34-0.98). Furthermore,
co-carriage of either PCV13-serotypes and S. aureus or
non-PCV13-serotypes and S. aureus increased the odds of
colonization by H. influenzae (AOR: 2.61, 95% CI: 1.51-4.51
and AOR: 4.87, 95% CI: 2.60-9.14, respectively). Concurrent
carriage of H. influenzae and S. aureus increased the
odds of colonization by S. pneumoniae (AOR: 2.28, 95%
CI: 1.31-3.97), including colonization by PCV13-serotypes
(AOR: 1.90, 95% CI: 1.05-3.45) and non-PCV13-serotypes
(AOR: 4.16, 95% CI: 2.24-7.33). Thus, competitive interac-
tions between H. influenzae and S. aureus or S. pneumoniae
and S. aureus shifted to synergistic when concurrent
S. pneumoniae and H. influenzae carriage were present.
There was no association between carriage of S. aureus
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Figure 1 Prevalence of S. pneumoniae, H. influenzae and S.
aureus in children and mothers. Proportion of samples positive for
S. pneumoniae, H. influenzae and S. aureus in children (top) and
mothers (bottom) stratified by child age, represented by bars. Cubic
functions, represented by lines, giving prevalence trends are shown
for each bacterium.
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given dual carriage of S. pneumoniae and H. influenzae
(AOR: 1.71, 95% CI: 0.95-3.06) (Table 1). Of the other risk
factors, age and influenza virus season were positively
associated with colonization by both S. pneumoniae and
H. influenzae. The presence of a child attending day care
in the household increased the odds of colonization by
H. influenzae (AOR: 1.51, 95% CI: 1.09-2.08).
Bacterial interactions in mothers
Overall detection of colonization in mothers across all
study visits were 18.9% (345/1830) for S. pneumoniae, 4.5%
(83/1830) for H. influenzae and 52.1% (953/1830) for S.
aureus. No interactions were observed between the three
bacteria in mothers, even when analyzing the composite
data of HIV-infected and -uninfected mothers (Table 2).
This was also true even if the women were stratified by
HIV-infection status (data not shown). Age of the mother
was negatively associated with colonization by S.
pneumoniae (AOR: 0.94, 95% CI: 0.93-0.95) and H.
influenzae (AOR: 0.93, 95% CI: 0.91-0.96), and positively as-
sociated with colonization by S. aureus (AOR: 1.02,
95% CI: 1.01-1.03).
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Figure 2 Comparison of observed and calculated prevalence in children. Observed prevalence of dual and triple carriage in children (i.e.
pattern filled bars) and calculated prevalence given by random models (i.e. solid filled bars). Here HEU means HIV-uninfected children born to
HIV-infected mothers and HUU mean HIV-uninfected children born to HIV-uninfected mothers. aP (S.pneumoniae, H.influenzae) - observed
probability that a child carried both S. pneumoniae and H. influenzae. bP (S. pneumoniae) P (H. influenzae) – calculated (or expected) probability of
dual carriage under the assumption that co-carriage is an independent process
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Colonization correlation statuses of mothers and children
The proportion of children who ever carried S.
pneumoniae during the study period was one and half-
fold greater compared to mothers (95.6% vs. 66.1%;
p < 0.0001), three-fold greater for H. influenzae (84.1%
vs. 26.3%; p < 0.0001), while the proportion of children
ever colonized by S. aureus was 15% lower than that of
mothers (74.9% vs. 88.1%; p = 0.0001). We explored the
colonization correlation statuses of mothers and chil-
dren, i.e., the interrelationship of the three bacteria in
mothers taking into account bacterial colonization in the
children, and vice-versa with the results given in Table 3.
Colonization statuses of children and mothers were
correlated, i.e. carriage of a particular bacterium by the
mother increased the odds of carriage of the same bac-
terium by the child, and vice versa. Carriage of S.
pneumoniae, H. influenzae and S. aureus by mothers in-
creased the odds of colonization in children (AOR: 1.57,
95% CI: 1.04-2.39; AOR: 2.43, 95% CI: 1.19-4.97 and
AOR: 1.65, 95% CI: 1.28-2.13, respectively) (Table 3).
Similarly, carriage of S. pneumoniae, H. influenzae and
S. aureus by children increased the odds of colonization
in mothers (AOR: 1.84, 95% CI: 1.28-2.63; AOR: 6.34,
95% CI: 2.24-18.0 and AOR: 1.56, 95% CI: 1.13-2.17, re-
spectively). Observations were similar for PCV13 and
non-PCV13 serotypes (data not shown). In this com-
bined full mixing model, the interrelationships of the
three bacteria in children were preserved, i.e. synergy
and antagonistic effects of bacteria were observed in
children while there were no relationships in mothers
when analysis was confined to individual populations,
i.e. children or mothers group separately.
Discussion
In this analysis we explored the association of S.
pneumoniae, H. influenzae and S. aureus colonization
within and between children and their mothers. In
children, the probabilities of dual and triple colonization
were identified concurrently more often than would
be expected by chance. We observed well-defined
Table 1 Interaction between Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus
nasopharyngeal colonization in children <2 years of age
Independent variable Dependent variable
S. pneumoniae H. influenzae S. aureus
S. pneumoniae PCV13b Non-PCV13c
S. pneumoniae colonizationa - - - 1.14(0.90,1.44) 0.68(0.50,0.93)
PCV13 - - - 1.45(1.09,1.93) 0.74(0.52,1.06)
Non-PCV13 - - - 1.35(0.96,1.90) 0.62(0.42,0.92)
H. influenzae colonization 1.75(1.32,2.32) 1.75(1.28,2.39) 1.36(0.96,1.91) - 0.58(0.34,0.98)
S. aureus colonization 0.51(0.39,0.67) 0.48(0.36,0.65) 0.39(0.29,0.54) 0.24(0.16,0.34) -
Age of child 1.09(1.06,1.10) 1.08(1.05,1.10) 1.05(1.02,1.07) 1.05(1.03,1.07) 0.95(0.93,0.96)
Influenza season (1-influenza season, 0-peri influenza season) 1.37(1.06,1.77) 1.46(1.11,1.93) 1.45(1.05,1.98) 1.54(1.21,1.96) 0.93(0.70,1.24)
Season of the year 0.88(0.80,0.97) 0.80(0.72,0.89) 0.74(0.66,0.82) 0.69(0.63,0.76) 0.86(0.78,0.95)
Any child between 3–6 years in the household (y/n) 1.19(0.92,1.56) 1.06(0.78,1.44) 0.99(0.71,1.38) 0.89(0.68,1.16) 0.94(0.68,1.29)
Use of Coal/Wood for fuel (y/n) 1.58(0.98,2.54) 1.14(0.64,2.03) 1.43(0.73,2.82) 0.49(0.26,0.90) 1.49(0.84,2.65)
Child attending day care (y/n) 0.83(0.59,1.16) 0.84(0.59,1.19) 0.84(0.55,1.28) 1.51(1.09,2.08) 1.34(0.99,1.83)
Any smoker in the household (y/n) 0.94(0.70,1.26) 0.79(0.57,1.08) 0.85(0.61,1.19) 0.76(0.58,1.02) 1.13(0.86,1.49)
Bacterial interactions
H. influenzae and S. aureus 2.28(1.31,3.97) 1.90(1.05,3.45) 4.16(2.24,7.73) - -
H. influenzae and S. pneumoniae - - - - 1.74(0.95,3.17)
S. pneumoniae and S. aureus - - - 3.59(2.24,5.76) -
H. influenzae and PCV13-serotype - - - - 1.37(0.70,2.67)
S. aureus and PCV13-serotype - - - 2.61(1.51,4.51) -
H. influenzae and non-PCV13-serotype - - - - 2.50(1.27,4.91)
S. aureus and non-PCV13-serotype - - - 4.87(2.60,9.14) -
The table shows the odds of carriage (and 95% confidence intervals; 95%CI) of a particular bacterium given the presence/absence of other pathogens adjusted for
other risk factors. Subjects who were not colonized by any pneumococci were the reference group. Seasons of the year were categorized as Summer (December–
February), Autumn (March–May), Winter (June–August) and Spring (September–November). The timing of the influenza epidemic was determined according to
the national influenza surveillance program conducted at the National Institute for Communicable Diseases.
aAll pneumococci, bPCV13 – serotypes included in the thirteen-valent pneumococcal conjugate vaccine, i.e. serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F
and 23F. cNon-PCV13- all serotypes not included in PCV13.
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relationships of the three bacteria in children. Our re-
sults showed that exposure to maternal-HIV in these
children did not change the colonization patterns by the
three bacteria. There is limited data on bacterial interac-
tions in the nasopharynx of adults; and unlike in chil-
dren no interactions between colonizing bacteria were
observed in the mothers. Colonization with the three
bacteria in children and mothers was positively
associated.
Our results among children corroborate that there is a
synergistic relationship between S. pneumoniae and H.
influenzae colonization and a negative association be-
tween S. pneumoniae and S. aureus, or H. influenzae
and S. aureus colonization [1,7-10,15]. Further evidence
of interaction of bacteria in the nasopharynx are evident
from animal-model studies in which H. influenzae
colonization was more likely when preceded by either S.
aureus or S. pneumoniae colonization, while under some
conditions H. influenzae limited colonization by S.
pneumoniae [22].
In children, prior co-colonization by S. pneumoniae
and S. aureus increased the risk of acquiring H.
influenzae, while dual carriage of H. influenzae and S.
aureus showed a trend for increasing risk for S.
pneumoniae colonization. Thus, the additional presence
of H. influenzae or S. pneumoniae might alter the com-
petitive balance between S. aureus and S. pneumoniae or
H. influenzae and all three pathogens are able to
colonize simultaneously as was also reported by
Pettigrew et al. [23]. These relations were not differen-
tially affected by pneumococcal serotype colonization
status. Thus, the cause, effect and consequences of these
bacterial interactions in the nasopharynx warrants fur-
ther study.
The well-defined associations observed in children
were, however, not detected in the mothers, even when
mothers were stratified by HIV-infection status. This
suggests that bacterial interactions in the nasopharynx
may be affected by biological factors of the bacteria,
coupled with host immunity factors which mature with
Table 2 Interaction between Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus
nasopharyngeal colonization in mothers
Independent variable Dependent variable
S. pneumoniae H. influenzae S. aureus
S. pneumoniae PCV13b Non-PCV13c
S. pneumoniae colonizationa - - - 1.14(0.56,2.30) 0.83(0.63,1.10)
PCV13 - - - 0.79(0.23,2.68) 0.85(0.60,1.21)
Non-PCV13 - - - 1.49(0.65,3.45) 0.81(0.57,1.16)
H. influenzae colonization 1.48(0.74,2.97) 0.97(0.31,3.07) 2.03(0.91,4.54) - 1.04(0.64,1.69)
S. aureus colonization 0.77(0.57,1.03) 0.76(0.52,1.12) 0.72(0.51,1.03) 0.66(0.40,1.08) -
Age of the mother 0.94(0.93,0.95) 0.91(0.90,0.93) 0.93(0.91,0.95) 0.93(0.91,0.96) 1.02(1.01,1.03)
Influenza season (1-influenza season, 0-peri influenza season) 1.00(0.75,1.33) 0.96(0.65,1.42) 1.06(0.72,1.55) 1.52(0.85,2.74) 0.87(0.70,1.09)
Season of the year 1.16(1.01,1.32) 1.19(0.99,1.43) 1.05(0.89,1.24) 0.64(0.47,0.88) 0.88(0.80,0.98)
Any child between 3–6 years in the household (y/n) 0.72(0.51,1.02) 0.73(0.45,1.19) 0.70(0.45,1.09) 1.09(0.59,2.01) 0.80(0.59,1.08)
Use of Coal/Wood for fuel (y/n) 1.56(0.91,2.67) 1.40(0.65,3.01) 1.49(0.71,3.12) 0.66(0.09,5.04) 0.88(0.44,1.76)
Any child attending day care in the household (y/n) 1.20(0.89,1.62) 1.37(0.89,2.10) 1.01(0.68,1.51) 1.02(0.54,1.90) 1.10(0.83,1.47)
Any smoker in the household (y/n) 0.99(0.71,1.39) 1.00(0.64,1.57) 1.02(0.68,1.54) 0.81(0.48,1.35) 0.93(0.70,1.25)
Bacterial interactions
H. influenzae and S. aureus 1.50(0.54,4.17) 1.85(0.38,9.09) 1.34(0.41,4.42) - -
H. influenzae and S. pneumoniae - - - - 1.20(0.50,2.89)
S. pneumoniae and S. aureus - - - 1.97(0.71,5.46) -
H. influenzae and PCV13-serotype - - - - 1.55(0.36,6.64)
S. aureus and PCV13-serotype - - - 2.33(0.49,11.0) -
H. influenzae and non-PCV13-serotype - - - - 1.16(0.45,2.96)
S. aureus and non-PCV13-serotype - - - 1.81(0.55,6.01) -
The table shows the odds of carriage (and 95% confidence intervals; 95%CI) of a particular bacterium given the presence/absence of other pathogens adjusted for
other risk factors. Subjects who were not colonized by any pneumococci were the reference group. Seasons of the year were categorized as Summer (December–
February), Autumn (March–May), Winter (June–August) and Spring (September–November). The timing of the influenza epidemic was determined according to
the national influenza surveillance program conducted at the National Institute for Communicable Diseases aAll pneumococci, bPCV13 – serotypes included in the
thirteen-valent pneumococcal conjugate vaccine, i.e. serotypes 1, 3, 4,5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F, cNon-PCV13-all serotypes not included in PCV13.
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Table 3 Colonization correlation statuses of mothers and children
Dependent
variable
Independent variables
Carriage in children Carriage in mothers
S.
pneumoniae
H.
influenzae
S. aureus S.
pneumoniae
and
S.
pneumoniae
and
H.influenzae
and
S.
pneumoniae
H.
influenzae
S.aureus H.influenzae
and
S.
pneumoniae
and
S.
pneumoniae
and
H.influenzae S.aureus S.aureus S.aureus H.influenzae S.aureus
Colonization in
children
S. pneumoniae - 2.59 0.48 - - 1.83 1.57 1.70 1.16 0.95 1.96 1.09
1.97–3.40 0.36–0.64 1.11–3.44 1.04–2.39 0.65–4.45 0.90–1.51 0.27–3.32 0.53–7.23 0.59–2.01
H. influenzae 2.88 0.49 1.67 1.04 2.43 0.71 3.31 0.48 1.37
2.24–3.70 0.30–0.79 0.94–2.96 0.73–1.50 1.19–4.97 0.56–0.90 1.26–8.69 0.16–1.47 0.85–2.21
S. aureus 0.50 0.45 - 1.91 - - 1.03 1.11 1.65 0.71 0.78 1.09
0.38–0.66 0.27–0.75 1.06–3.43 0.70–1.54 0.44–2.82 1.28–2.13 0.25–2.05 0.22–2.71 0.64–1.87
Colonization in
mothers
S. pneumoniae 1.84 1.41 1.02 0.83 1.18 0.77 1.22 0.79 1.37
1.28–2.63 0.81–2.48 0.62–1.69 0.45–1.53 0.63–2.21 0.41–1.44 0.62–2.43 0.60–1.05 0.53–3.52
H. influenzae 1.67 6.34 0.35 0.55 4.49 0.56 1.38 - 1.06 - - 1.14
0.69–4.07 2.24–18.0 0.07–1.87 0.18–1.70 0.87–23.3 0.19–1.66 0.69–2.79 0.62–1.82 0.45–2.88
S. aureus 1.19 0.80 1.56 1.12 0.98 0.87 0.80 1.07 1.22
0.92–1.53 0.54–1.17 1.13–2.17 0.73–1.72 0.61–1.57 0.55–1.40 0.62–1.04 0.68–1.69 0.54–2.72
Association of colonization with all pneumococci with H. influenzae and S. aureus.
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age, as well as possibly other environmental factors [15].
We observed that carriage of a particular bacterium by
the mother was a risk factor for the child, and vice-versa
suggesting that direct transmission between the two
groups may play a role in bacterial colonization among
them. This result, similar to a previous study [13], shows
that nasopharyngeal colonization status in mothers
with any of the three bacteria was correlated with
colonization status of their children.
Though we established well defined relationships of these
bacteria in children and lack of thereof in adult woman, our
study has some limitations. First, we only sampled NP
swabs in the children, which may underestimate prevalence
of S. aureus colonization in children. Also, we did not
undertake genotyping of the S. aureus strains and the other
two bacteria, therefore we were unable to address whether
the S. aureus transmission was between the mothers and
children or from the environment. Furthermore, our
study was not designed to address disease caused by
these pathogens, but rather focussed on colonization by
these pathogens. In spite of these limitations, this work
provide pre-PCV immunization data which may serve
as a reference to follow-up studies to determine what
effect childhood PCV immunization may have on bac-
terial ecology of the nasopharynx.
Conclusions
The results of this study suggest that before pneumococcal
conjugate vaccine introduction, bacterial co-infections are
more important in young children than in adults. Further
studies are required to evaluate the effect of childhood
PCV immunization on the potential changes of pharyngeal
bacterial ecology and disease in vaccinated and unvaccin-
ated populations.
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